AgomAb Therapeutics NV
Ownership
Ownership Structure
Who owns AgomAb Therapeutics NV (AGMB)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 35.2% of the shares are freely tradable; institutional investors hold 49.0%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| EQT Fund Management S.à r.l. | 10.44 | 5,141,992 | +0.0 | 06/30/2026 |
| Nantahala Capital Management, LLC | 6.37 | 3,136,376 | +161.4 | 06/30/2026 |
| Sanofi | 5.65 | 2,783,096 | +0.0 | 09/30/2026 |
| Redmile Group, LLC | 5.55 | 2,733,926 | +1,649.7 | 06/30/2026 |
| Cormorant Asset Management, LLC | 5.01 | 2,465,348 | +0.0 | 06/30/2026 |
| TCG Crossover Management, LLC | 4.17 | 2,053,233 | +0.0 | 06/30/2026 |
| Federated Hermes Inc | 3.29 | 1,618,000 | +0.0 | 06/30/2026 |
| Casdin Capital, LLC | 3.15 | 1,550,000 | +0.0 | 06/30/2026 |
| Andera Partners | 3.12 | 1,538,702 | +0.0 | 06/30/2026 |
| FMR Inc | 2.96 | 1,458,677 | +0.0 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Epstein David R | Director | 40,000 | 256,000 $ | Nov 5, 2026 | direct |
| Knotnerus Tim Jasper | Chief Executive Officer | 21,823 | 139,667 $ | Oct 6, 2026 | direct |
| Kemula Pierre Thadee Victor | Chief Financial Officer | 10,000 | 64,000 $ | Oct 6, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | Epstein David R | Director | Buy | 5,000 | 6.98 | 34,900 |
| Oct 21, 2026 | Epstein David R | Director | Buy | 5,000 | 8.90 | 44,500 |
| Oct 8, 2026 | Epstein David R | Director | Buy | 5,000 | 8.90 | 44,500 |
| Oct 6, 2026 | Knotnerus Tim Jasper | Chief Executive Officer | Buy | 5,000 | 8.70 | 43,500 |
| Oct 6, 2026 | Kemula Pierre Thadee Victor | Chief Financial Officer | Buy | 2,000 | 8.54 | 17,080 |
| Oct 6, 2026 | Kemula Pierre Thadee Victor | Chief Financial Officer | Buy | 5,000 | 8.57 | 42,850 |
| Oct 6, 2026 | Kemula Pierre Thadee Victor | Chief Financial Officer | Buy | 3,000 | 8.67 | 26,010 |
| Oct 6, 2026 | Epstein David R | Director | Buy | 5,000 | 8.70 | 43,500 |
| Oct 5, 2026 | Knotnerus Tim Jasper | Chief Executive Officer | Buy | 6,000 | 8.48 | 50,880 |
| Oct 5, 2026 | Epstein David R | Director | Buy | 5,000 | 8.57 | 42,850 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.